Precision medicine is no longer a concept reserved for research laboratories or academic textbooks; it has become a tangible reality reshaping how patients receive care in Central Florida. At the forefront of this transformation stands AdventHealth Medical Group Genomics and Personalized Health at Orlando, a dedicated clinical program designed to translate complex genetic data into actionable, individualized treatment plans. By integrating advanced genomic sequencing with multidisciplinary clinical expertise, this program empowers physicians to move beyond a one-size-fits-all approach, offering patients targeted therapies, proactive risk assessments, and a deeper understanding of their unique biological blueprint.
The Evolution of Personalized Medicine in Central Florida
The landscape of healthcare is shifting from reactive disease management to proactive, predictive wellness. That's why traditional medical protocols often rely on population-based averages—treating the "average patient" with standard dosages and screening schedules. Still, individual responses to medication, susceptibility to disease, and metabolic variations are deeply rooted in our DNA.
Easier said than done, but still worth knowing Simple, but easy to overlook..
AdventHealth Medical Group Genomics and Personalized Health at Orlando bridges the gap between genomic science and bedside clinical application. The program serves as a hub where genetic counselors, medical geneticists, oncologists, cardiologists, and pharmacists collaborate to interpret genomic findings. This collaborative model ensures that a genetic variant identified in a lab report is immediately contextualized within the patient’s full clinical picture, family history, and lifestyle factors.
Comprehensive Clinical Services Offered
The scope of services at this Orlando location extends far beyond simple ancestry testing or single-gene analysis. The program is structured around several key pillars of genomic medicine, each addressing specific patient needs across the lifespan Worth knowing..
Hereditary Cancer Risk Assessment
One of the most impactful applications of clinical genomics is identifying hereditary cancer syndromes. Patients with a personal or strong family history of breast, ovarian, colorectal, pancreatic, or prostate cancer are evaluated for mutations in genes such as BRCA1, BRCA2, MLH1, MSH2, and others associated with Lynch syndrome and other hereditary conditions.
Identifying a pathogenic variant allows for risk-stratified surveillance. Even so, for example, a patient with a BRCA1 mutation may begin breast MRI screening at age 25 rather than 40, or consider risk-reducing surgery. What's more, these results have profound implications for family members, enabling cascade testing where relatives can be tested for the specific familial variant, providing them with the power of early detection or the relief of a true negative result Took long enough..
Pharmacogenomics: Right Drug, Right Dose, First Time
Adverse drug reactions are a leading cause of hospital admissions. Pharmacogenomics (PGx) analyzes how genetic variations affect an individual’s response to medications. The AdventHealth program utilizes PGx panels to guide prescribing for medications commonly used in cardiology, psychiatry, pain management, and oncology.
Key genes analyzed often include:
- CYP2C19: Critical for metabolizing clopidogrel (Plavix), a standard antiplatelet therapy post-stent placement. Practically speaking, poor metabolizers may require alternative therapy to prevent stent thrombosis. * CYP2D6 & CYP2C19: Influence the metabolism of many antidepressants and antipsychotics, helping psychiatrists avoid trial-and-error prescribing cycles.
- TPMT & NUDT15: Essential for dosing thiopurines (azathioprine, 6-mercaptopurine) used in autoimmune conditions and leukemia, preventing life-threatening myelosuppression.
- DPYD: Screens for dihydropyrimidine dehydrogenase deficiency prior to fluorouracil (5-FU) or capecitabine chemotherapy, preventing severe toxicity.
By embedding these results into the electronic health record (EHR) with clinical decision support alerts, the program ensures that prescribing physicians receive real-time guidance at the point of care Nothing fancy..
Cardiovascular Genomics
Inherited cardiovascular conditions—such as hypertrophic cardiomyopathy (HCM), long QT syndrome, familial hypercholesterolemia, and arrhythmogenic right ventricular cardiomyopathy (ARVC)—often present silently until a catastrophic event occurs. The genomics team works closely with the AdventHealth Heart, Lung, and Vascular Institute to provide genetic testing for patients diagnosed with these conditions and their at-risk relatives Nothing fancy..
A molecular diagnosis confirms the clinical suspicion, guides device implantation decisions (such as ICDs), informs family screening protocols, and can even dictate specific medication avoidance (e.Now, g. , avoiding certain sodium channel blockers in Long QT Type 3).
Rare and Undiagnosed Disease Diagnosis
For patients navigating a "diagnostic odyssey"—often spending years seeing specialists without a unifying diagnosis—exome sequencing (ES) and genome sequencing (GS) offer a path to answers. The program facilitates trio-based sequencing (patient plus both parents) to identify de novo mutations or recessive inheritance patterns responsible for complex neurodevelopmental disorders, congenital anomalies, and metabolic conditions. A definitive diagnosis ends the cycle of invasive testing, connects families with specific support networks, and informs reproductive planning.
The Patient Journey: From Consultation to Integration
Understanding the workflow at AdventHealth Medical Group Genomics and Personalized Health at Orlando demystifies the process for new patients and referring providers.
1. Referral and Triage
Referrals originate from primary care physicians, oncologists, cardiologists, OB/GYNs, or patient self-referral based on family history. A genetic counseling assistant often performs an initial intake to gather a detailed three-generation pedigree, ensuring the appropriate test is ordered from the start.
2. Pre-Test Genetic Counseling
This is a mandatory and distinct step. A board-certified genetic counselor meets with the patient (in-person or via telehealth) to discuss:
- The specific genes or panels being analyzed.
- Possible results: Positive (pathogenic/likely pathogenic variant), Negative (no variant found), or Variant of Uncertain Significance (VUS).
- Implications for insurance (GINA protections), family members, and psychological impact.
- Informed consent documentation.
3. Sample Collection and Analysis
Samples (blood, saliva, or buccal swab) are sent to accredited, CAP/CLIA-certified laboratories. The program maintains relationships with multiple reference labs to select the optimal platform—whether a focused multi-gene panel, exome sequencing, or a specialized pharmacogenomics array—based on clinical indication and insurance coverage Less friction, more output..
4. Post-Test Counseling and Result Disclosure
Results are never released to a patient portal without interpretation. A genetic counselor or medical geneticist reviews the report in detail. For positive results, a personalized management plan is generated immediately, referencing NCCN, ACMG, or CPIC guidelines. For VUS results, the team explains the limitations and the plan for re-analysis as scientific knowledge evolves.
5. Longitudinal Care Coordination
Genomic information is static (your DNA doesn't change), but clinical guidelines evolve. The program commits to re-analysis and re-contact initiatives. As new gene-disease associations are discovered or variant classifications are updated, the team proactively reviews archived data to ensure patients benefit from the latest science Simple, but easy to overlook..
The Role of Genetic Counselors: The Human Element of Genomics
While technology drives the data, genetic counselors are the translators and advocates. Day to day, at the Orlando location, these master’s-level trained professionals are integral to the care team. They possess the unique skillset to communicate probabilistic risk in understandable terms, deal with complex family dynamics surrounding disclosure, and provide psychosocial support.
They also serve as a resource for the broader AdventHealth medical staff, educating oncologists on new immunotherapy biomarkers, advising cardiologists on VUS management in channelopathies, and assisting primary care doctors in interpreting direct-to-consumer genetic test results patients bring in from home kits.
Technology Infrastructure and Data Integration
A critical differentiator for AdventHealth Medical Group Genomics and Personalized Health at Orlando is the investment in health information technology infrastructure. Genomic data files are massive and complex (VCF files,
